HomeMarkets Markets FDA Approves New First-Line Med for Pancreatic Cancer as Drug’s Initial Developer Dissolves By Ilene February 15, 2024 0 461 FacebookTwitterPinterestWhatsApp Ipsen’s Onivyde is now FDA approved as a first-line treatment for metastatic pancreatic cancer, triggering a milestone payment to Merrimack …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected149,644FansLike396,312FollowersFollow2,640SubscribersSubscribe Latest Articles AI ‘This is a platform shift’: Jensen Huang says the traditional computing stack will never look the same because of AI — Top Trades PSW Top Trade Alert – Jan 21st 2026 – HP, Inc. (HPQ) Market News Trump Drops Tariff Threat Over Greenland After Assailing Europe Top Trades PSW Top Trade Alert – Jan 21 2026 – Generac Holdings (GNRC) Hot Items Carney’s speech to World Economic Forum Markets As Trump’s threats over Greenland escalate, will Europe use its ‘trade bazooka’? Market News Trump Family Makes $1.4 Billion Off Crypto in 2025, Offsetting Losses Elsewhere Markets Wednesday’s World Economic Forum Report by Robo John Oliver Hot Items Robert Kagan: America vs. the World (a must read) Hot Items A Stark Warning About the 2026 Election, with Robert Kagan Energy ‘Unchecked Corruption’: First US Sale of Venezuelan Oil Goes to Company of Trump Megadonor Markets Tuesday Trumpiversary – Year Two (feels like year ten!) Begins in Turmoil Market News Trump’s demands put Europe in FAFO territory Hot Items Trump’s Letter to Norway Should Be the Last Straw Load more